About company
iVeena has five products in the late pre-clinical and research phases. Targeted indications include post-surgery cataract inflammation, macular degeneration (Wet AMD), diabetic retinopathy and glaucoma.
- US
- Unknown
- Unknown
- iveenamed.com/
- Not verified company
